In Vitro Evaluation of Current Thoracic Aortic Stent-Grafts for Real-time MR-Guided Placement

The past, present and future of minimally invasive therapy in endovascular interventions: a review and speculative outlook

Cardiovascular disease is a leading cause of death in all developed countries. In response to this need, endovascular management techniques have been developed across a large range of medical specialties. Minimally invasive percutaneous interventions were initially complex and challenging, but with the continued development of equipment and expertise their use has become routine in many fields. With routine use, it has become important to establish the safety and efficacy of endovascular treatments against the respective "gold standard" procedures, especially in light of their initial intended use for the management of patients at unacceptably high risk for standard therapy only. Such evaluation has to take into account the variety and diversity of devices and techniques, as well as the effects of operator dependability. Endovascular techniques are increasingly recognised as valid alternative management options for a variety of conditions, and it is anticipated that the current trend towards minimally invasive techniques will continue in the future, with moves towards increasingly complex endovascular techniques and hybrid interventions.

The role of mandatory lifelong annual surveillance after thoracic endovascular repair

Thoracic endovascular aortic repair (TEVAR) has become an attractive and well-accepted option for the management of the various thoracic aortic pathologies that vascular surgeons are confronted with. As in the abdominal aorta, current management trends include the treatment of younger patients with longer life expectancies, raising the issue of postoperative surveillance. There are several relevant differences between these anatomic areas when it comes to surveillance, including the relative inaccessibility of the thoracic aorta to ultrasound interrogation and the increased variability of thoracic aortic pathologies and post-TEVAR complications. In addition, concerns regarding radiation-induced carcinogenesis and contrast-induced nephropathy reduce the enthusiasm of many surgeons for regular computed tomography surveillance. Most agree that surveillance is important after TEVAR, but the method, duration, and frequency of that surveillance is much less clear and is the topic of this debate.

Interventional MRI in the cardiovascular system

Endovascular stent-graft placement for thoracic aortic disease such as aortic dissection or aortic aneurysms is usually performed under conventional X-ray guidance. The experimental concept of using magnetic resonance imaging (MRI) for image-based guidance of vascular instruments for this specific intervention potentially offers a number of features that - aside from not using ionizing radiation - may provide added diagnostic value to the interventional therapy. It allows not only pre-interventional evaluation and detailed anatomic diagnosis but also permits immediate post-interventional, anatomical, and functional delineation of procedure success that may serve as a baseline for future comparison during follow-up.

Towards real-time cardiovascular magnetic resonance-guided transarterial aortic valve implantation: in vitro evaluation and modification of existing devices

BACKGROUND

Cardiovascular magnetic resonance (CMR) is considered an attractive alternative for guiding transarterial aortic valve implantation (TAVI) featuring unlimited scan plane orientation and unsurpassed soft-tissue contrast with simultaneous device visualization. We sought to evaluate the CMR characteristics of both currently commercially available transcatheter heart valves (Edwards SAPIEN™, Medtronic CoreValve®) including their dedicated delivery devices and of a custom-built, CMR-compatible delivery device for the Medtronic CoreValve® prosthesis as an initial step towards real-time CMR-guided TAVI.

METHODS

The devices were systematically examined in phantom models on a 1.5-Tesla scanner using high-resolution T1-weighted 3D FLASH, real-time TrueFISP and flow-sensitive phase-contrast sequences. Images were analyzed for device visualization quality, device-related susceptibility artifacts, and radiofrequency signal shielding.

RESULTS

CMR revealed major susceptibility artifacts for the two commercial delivery devices caused by considerable metal braiding and precluding in vivo application. The stainless steel-based Edwards SAPIEN™ prosthesis was also regarded not suitable for CMR-guided TAVI due to susceptibility artifacts exceeding the valve's dimensions and hindering an exact placement. In contrast, the nitinol-based Medtronic CoreValve® prosthesis was excellently visualized with delineation even of small details and, thus, regarded suitable for CMR-guided TAVI, particularly since reengineering of its delivery device toward CMR-compatibility resulted in artifact elimination and excellent visualization during catheter movement and valve deployment on real-time TrueFISP imaging. Reliable flow measurements could be performed for both stent-valves after deployment using phase-contrast sequences.

CONCLUSIONS

The present study shows that the Medtronic CoreValve® prosthesis is potentially suited for real-time CMR-guided placement in vivo after suggested design modifications of the delivery system.

Feasibility of stent-graft placement with real-time MR fluoroscopy in a nonrigid aortic phantom

PURPOSE

To evaluate the feasibility of using real-time magnetic resonance (MR) fluoroscopic guidance to place a stent-graft mounted on a guide wire in a nonrigid aortic phantom.

MATERIALS AND METHODS

Real-time fast low-angle shot and true fast imaging with steady-state precession MR imaging sequences were used for device tracking. A modified fiber-optic guide wire and catheter embedded with titanium oxide in predefined positions were used for navigation in a homemade silicone thoracic aortic phantom.

RESULTS

Susceptibility artifacts caused by the modified guide wire and catheters mounted in the descending thoracic aorta of the phantom were found to enable adequate determination of the guide wire position in relation to the surrounding anatomy and to cause no image distortion. Real-time MR imaging enabled visualization of both the vessel lumen and the delivery system with the mounted stent-graft, providing an image quality sufficient for successful localization of the lesion and deployment of the stent-graft.

CONCLUSIONS

The results of this study prove the possibility of passive guidance in MR imaging-guided stent placement in vitro. The modified guide wire can be used with interventional commercial catheters and recent implant devices with selective tracking in the surrounding anatomy.

An overview on the advances in cardiovascular interventional MR imaging

Interventional cardiovascular magnetic resonance imaging (iCMR) represents a new discipline whose systematic development will foster minimally invasive interventional procedures without radiation exposure. New generations of open, wide and short bore MR scanners and real time sequences made cardiovascular intervention possible. MR compatible endovascular catheters and guide-wires are needed for delivery of devices such as stents or atrial septal defect (ASD) closures. Catheter tracking is based on active and passive approaches. Currently performed MR-guided procedures are used to monitor, navigate and track endovascular catheters and to deliver local therapeutic agents to targets, such as infarcted myocardium and vascular walls. Heating of endovascular MR catheters, guide-wires and devices during imaging still presents high safety risks. MR contrast media improve the capabilities of MR imaging by enhancing blood signal, pathologic targets (such as myocardial infarctions and atherosclerotic plaques), endovascular catheters and by tracking injected therapeutic agents. Labeling injected soluble therapeutic agents, genes or cells with MR contrast media enables interventionalists to ensure the administration of the drugs in the target and to trace their distribution in the targets. The future clinical use of this iCMR technique requires (1) high spatial and temporal resolution imaging, (2) special catheters and devices and (3) effective therapeutic agents, genes or cells. These conditions are available at a low scale at the present time and need to be developed in the near future. Such progress will lead to improved patient care and minimize invasiveness.

The effect of magnetic resonance imaging on stainless-steel Z-stent–based abdominal aortic prosthesis

OBJECTIVE

To assess the effects of magnetic resonance imaging (MRI) on stainless-steel Z-stent-based abdominal aortic prostheses.

METHODS

From June 1996 to December 2005, 550 patients underwent endovascular repair of an infrarenal abdominal aortic aneurysm at a single academic institution by using a stainless-steel Z-stent-based abdominal aortic prosthesis. Routine patient follow-up included computed tomography scans and abdominal plain films at 1, 6, and 12 months after surgery and yearly thereafter. Although patients were specifically instructed not to undergo MRI, retrospective review identified 22 patients (4%) who underwent MRI after stent-graft implantation.

RESULTS

Seventeen of 22 patients consented to have their records reviewed as part of this study and underwent MRI at a mean interval of 669 days (range, 3-2179 days) after stent-graft implantation. Eleven patients underwent implantation of Zenith bifurcated stent grafts, and six had custom-made uni-iliac stent grafts. These patients underwent a total of 20 MRI studies-10 of the brain/neck and 10 of the abdomen, pelvis, or spine. In all cases, the magnetic field strength was 1.5 T or less. No patient experienced any symptoms of abdominal or back pain during or after the MRI. Comparison of the pre- and post-MRI computed tomography scans (available in 15 of 17 patients) and abdominal radiographs showed no change in stent-graft structure, position, or function in any of these patients and no increase in abdominal aortic aneurysm diameter in any patient at an average of 899 days after MRI.

CONCLUSIONS

On the basis of this limited experience, MRI has no discernible effect on the structure, position, or function of stainless-steel Z-stent-based abdominal aortic prostheses.

Real-time vascular interventional magnetic resonance imaging

Endovascular stent-graft placement is emerging as a promising alternative to medical and surgical treatment of patients with diseases of the descending thoracic and abdominal aorta. Precise placement of the stentgraft, which is currently performed under x-ray control, remains, however, challenging as there are several shortcomings to fluoroscopic guidance beyond that related to the harmful effect of radiation exposure and nephrotoxic contrast media. While transesophageal echocardiography and intravascular ultrasound have been used as adjunct imaging modalities during endovascular stent-graft procedures to overcome the limitations of angiography, these techniques have not mitigated the need for fluoroscopy. Magnetic resonance imaging (MRI) guidance of vascular interventional procedures offers several potential advantages over fluoroscopy-guided techniques, including image acquisition in any desired orientation, superior 3D soft-tissue contrast with simultaneous visualization of the interventional device, absence of ionizing radiation, and avoidance of nephrotoxic contrast media. Magnetic resonance imaging is often used for pre-operative diagnosis of aortic disease and can provide all relevant information for the planning of endovascular stent-graft procedures as well as for accurate and immediate post-interventional evaluation. However, visualization of interventional instruments by MRI has proven to be the chief obstacle. This article will review current approaches that have been developed for depicting vascular instruments by MRI and will also discuss the first experimental experiences with MRI-guided endovascular stent-graft placement in a swine model of aortic dissection.

Feasibility of real-time magnetic resonance-guided stent-graft placement in a swine model of descending aortic dissection

AIMS

To evaluate the pre-clinical feasibility of real-time magnetic resonance imaging (rtMRI) to guide stent-graft placement for experimental aortic dissection (AD) and to alleviate disadvantages of ionising radiation and nephrotoxic contrast media. Endovascular stent-graft placement for thoracic aortic disease is usually performed under X-ray guidance. The feasibility of rtMRI-guided stent-graft placement is currently not known.

METHODS AND RESULTS

By using a catheter-based technique, dissections of the descending thoracic aorta were successfully created in eight domestic pigs. Subsequent implantation of commercially available, nitinol-based stent-grafts was performed entirely under rtMRI guidance. By pre-interventional MRI, the mean minimal true-lumen diameter was 0.9 (0.825-0.975) cm. rtMRI permitted not only the successful and safe device navigation within the true lumen from the iliac arteries to the thoracic aorta, but also the precise positioning and deployment of the stent-graft and safe withdrawal of the delivery catheter in seven of eight pigs. This was achieved without any other complications. After the stent-graft placement, MRI demonstrated complete obliteration of the false lumen, which was confirmed at autopsy. All stent-grafts were well expanded resulting in an increase in the size of the true-lumen diameter to 2.05 (1.925-2.1) cm (P=0.066 vs. baseline).

CONCLUSION

In experimental AD, rtMRI-guided endovascular stent-graft placement is feasible and safe and has the potential for mitigating radiation and contrast-related side effects. Additionally, it allows not only pre-interventional diagnosis and detailed anatomic diagnosis, but also permits immediate post-interventional, anatomical, and functional delineation of procedure success that may serve as a baseline for future comparison during follow-up.